116 related articles for article (PubMed ID: 18538173)
21. Vinflunine.
Shnyder SD
IDrugs; 2004 Sep; 7(9):851-9. PubMed ID: 15470603
[TBL] [Abstract][Full Text] [Related]
22. Microtubule-binding natural products for cancer therapy.
Yue QX; Liu X; Guo DA
Planta Med; 2010 Aug; 76(11):1037-43. PubMed ID: 20577942
[TBL] [Abstract][Full Text] [Related]
23. Vinblastine, a chemotherapeutic drug, inhibits palmitoylation of tubulin in human leukemic lymphocytes.
Caron JM; Herwood M
Chemotherapy; 2007; 53(1):51-8. PubMed ID: 17202812
[TBL] [Abstract][Full Text] [Related]
24. Stathmin/Op18 is a novel mediator of vinblastine activity.
Devred F; Tsvetkov PO; Barbier P; Allegro D; Horwitz SB; Makarov AA; Peyrot V
FEBS Lett; 2008 Jul; 582(17):2484-8. PubMed ID: 18588888
[TBL] [Abstract][Full Text] [Related]
25. Vinflunine: a novel antitubulin agent in solid malignancies.
Bennouna J; Campone M; Delord JP; Pinel MC
Expert Opin Investig Drugs; 2005 Oct; 14(10):1259-67. PubMed ID: 16185168
[TBL] [Abstract][Full Text] [Related]
26. Vinorelbine in cancer therapy.
Capasso A
Curr Drug Targets; 2012 Jul; 13(8):1065-71. PubMed ID: 22594474
[TBL] [Abstract][Full Text] [Related]
27. [Microtubule inhibitors--its application to the research field of hard tissues (author's transl)].
Ogura H
Kokubyo Gakkai Zasshi; 1981 Jun; 48(2):199-218. PubMed ID: 7026704
[No Abstract] [Full Text] [Related]
28. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
Simoens C; Pauwels B; Vermorken JB; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2008 Jul; 62(2):183-93. PubMed ID: 17899084
[TBL] [Abstract][Full Text] [Related]
29. Taccalonolides: Novel microtubule stabilizers with clinical potential.
Risinger AL; Mooberry SL
Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
[TBL] [Abstract][Full Text] [Related]
30. 7-Diethylamino-3(2'-benzoxazolyl)-coumarin is a novel microtubule inhibitor with antimitotic activity in multidrug resistant cancer cells.
Kim SN; Kim NH; Park YS; Kim H; Lee S; Wang Q; Kim YK
Biochem Pharmacol; 2009 Jun; 77(12):1773-9. PubMed ID: 19428332
[TBL] [Abstract][Full Text] [Related]
31. Antiangiogenic vinflunine affects EB1 localization and microtubule targeting to adhesion sites.
Honoré S; Pagano A; Gauthier G; Bourgarel-Rey V; Verdier-Pinard P; Civiletti K; Kruczynski A; Braguer D
Mol Cancer Ther; 2008 Jul; 7(7):2080-9. PubMed ID: 18645018
[TBL] [Abstract][Full Text] [Related]
32. [The regulation of tubulin by vinblastine].
Gigant B; Wang C; Ravelli R; Knossow M
Med Sci (Paris); 2005 Oct; 21(10):814-5. PubMed ID: 16197897
[No Abstract] [Full Text] [Related]
33. Vinorelbine induces beta3-tubulin gene expression through an AP-1 Site.
Saussede-Aim J; Matera EL; Herveau S; Rouault JP; Ferlini C; Dumontet C
Anticancer Res; 2009 Aug; 29(8):3003-9. PubMed ID: 19661308
[TBL] [Abstract][Full Text] [Related]
34. Differential binding to the alpha/beta-tubulin dimer of vinorelbine and vinflunine revealed by nuclear magnetic resonance analyses.
Fabre C; Czaplicki J; Wright M; Hill B; Barret JM; Fahy J; Milon A
Biochem Pharmacol; 2002 Aug; 64(4):733-40. PubMed ID: 12167492
[TBL] [Abstract][Full Text] [Related]
35. Microtubule active agents: beyond the taxane frontier.
Morris PG; Fornier MN
Clin Cancer Res; 2008 Nov; 14(22):7167-72. PubMed ID: 19010832
[TBL] [Abstract][Full Text] [Related]
36. Syntheses and biological evaluation of vinblastine congeners.
Kuehne ME; Bornmann WG; Markó I; Qin Y; LeBoulluec KL; Frasier DA; Xu F; Mulamba T; Ensinger CL; Borman LS; Huot AE; Exon C; Bizzarro FT; Cheung JB; Bane SL
Org Biomol Chem; 2003 Jun; 1(12):2120-36. PubMed ID: 12945903
[TBL] [Abstract][Full Text] [Related]
37. Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro.
Shi YQ; Zhu CJ; Yuan HQ; Li BQ; Gao J; Qu XJ; Sun B; Cheng YN; Li S; Li X; Lou HX
Cancer Lett; 2009 Apr; 276(2):160-70. PubMed ID: 19095349
[TBL] [Abstract][Full Text] [Related]
38. Microtubule-damaging agents enhance RASSF1A-induced cell death in lung cancer cell lines.
Whang YM; Park KH; Jung HY; Jo UH; Kim YH
Cancer; 2009 Mar; 115(6):1253-66. PubMed ID: 19156899
[TBL] [Abstract][Full Text] [Related]
39. New prospects for vinblastine analogues as anticancer agents.
Silvestri R
J Med Chem; 2013 Feb; 56(3):625-7. PubMed ID: 23316748
[TBL] [Abstract][Full Text] [Related]
40. [Microtubule depolymerization inhibitor].
Kouno T
Nihon Rinsho; 2015 Feb; 73 Suppl 2():167-73. PubMed ID: 25831745
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
